Overview

Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Pilot study to compare the efficacy and safety of two strengths of injections of subcutaneous DFN-11 in subjects with rapidly escalating migraine headaches.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Sumatriptan